Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ábel Nagy

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Molecular Imaging and Biology|April 13, 2023
Site-Specific Photoaffinity Bioconjugation for the Creation of <sup>89</sup>Zr-Labeled RadioimmunoconjugatesSamantha Delaney, Ábel Nagy, Amelie Eriksson Karlström, et al.
ACS Omega|September 2, 2024
Evaluation of ABD-Linked RM26 Conjugates for GRPR-Targeted Drug DeliveryÁbel Nagy, Ayman Abouzayed, Panagiotis Kanellopoulos, et al.
Biosensors & Bioelectronics|January 9, 2021
Electrokinetic sandwich assay and DNA mediated charge amplification for enhanced sensitivity and specificitySiddharth Sourabh Sahu, Christiane Stiller, Elizabeth Paz Gomero, et al.
ACS Applied Materials & Interfaces|September 2, 2021
Exploiting Electrostatic Interaction for Highly Sensitive Detection of Tumor-Derived Extracellular Vesicles by an Electrokinetic SensorSiddharth Sourabh Sahu, Sara Cavallaro, Petra Hååg, et al.
Biosensors & Bioelectronics|February 22, 2023
Multi-marker profiling of extracellular vesicles using streaming current and sequential electrostatic labelingSiddharth S Sahu, Moein T Gevari, Ábel Nagy, et al.
Pharmaceutics|October 21, 2020
Preclinical Evaluation of the GRPR-Targeting Antagonist RM26 Conjugated to the Albumin-Binding Domain for GRPR-Targeting Therapy of CancerAyman Abouzayed, Hanna Tano, Ábel Nagy, et al.
European Journal of Medicinal Chemistry|October 8, 2024
Impact of site-specific conjugation strategies on the pharmacokinetics of antibody conjugated radiotherapeuticsÁbel Nagy, David Ulmert, Wahed Zedan, et al.
European Journal of Medicinal Chemistry|January 20, 2026
Corrigendum to "Impact of site-specific conjugation strategies on the pharmacokinetics of antibody-conjugated radiotherapeutics" [Eur J Med Chem. 2024 Dec 15; 280:116927. doi: 10.1016/j.ejmech.2024.116927. PMID: 39378827]Ábel Nagy, David Ulmert, Wahed Zedan, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 22, 2025
Optimizing peptide nucleic acid-based pretargeting for enhanced targeted radionuclide therapyMohamed Altai, Ábel Nagy, Pauline Granit, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Molecular Imaging and Biology|April 13, 2023
Site-Specific Photoaffinity Bioconjugation for the Creation of <sup>89</sup>Zr-Labeled RadioimmunoconjugatesSamantha Delaney, Ábel Nagy, Amelie Eriksson Karlström, et al.
ACS Omega|September 2, 2024
Evaluation of ABD-Linked RM26 Conjugates for GRPR-Targeted Drug DeliveryÁbel Nagy, Ayman Abouzayed, Panagiotis Kanellopoulos, et al.
Biosensors & Bioelectronics|January 9, 2021
Electrokinetic sandwich assay and DNA mediated charge amplification for enhanced sensitivity and specificitySiddharth Sourabh Sahu, Christiane Stiller, Elizabeth Paz Gomero, et al.
ACS Applied Materials & Interfaces|September 2, 2021
Exploiting Electrostatic Interaction for Highly Sensitive Detection of Tumor-Derived Extracellular Vesicles by an Electrokinetic SensorSiddharth Sourabh Sahu, Sara Cavallaro, Petra Hååg, et al.
Biosensors & Bioelectronics|February 22, 2023
Multi-marker profiling of extracellular vesicles using streaming current and sequential electrostatic labelingSiddharth S Sahu, Moein T Gevari, Ábel Nagy, et al.
Pharmaceutics|October 21, 2020
Preclinical Evaluation of the GRPR-Targeting Antagonist RM26 Conjugated to the Albumin-Binding Domain for GRPR-Targeting Therapy of CancerAyman Abouzayed, Hanna Tano, Ábel Nagy, et al.
European Journal of Medicinal Chemistry|October 8, 2024
Impact of site-specific conjugation strategies on the pharmacokinetics of antibody conjugated radiotherapeuticsÁbel Nagy, David Ulmert, Wahed Zedan, et al.
European Journal of Medicinal Chemistry|January 20, 2026
Corrigendum to "Impact of site-specific conjugation strategies on the pharmacokinetics of antibody-conjugated radiotherapeutics" [Eur J Med Chem. 2024 Dec 15; 280:116927. doi: 10.1016/j.ejmech.2024.116927. PMID: 39378827]Ábel Nagy, David Ulmert, Wahed Zedan, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 22, 2025
Optimizing peptide nucleic acid-based pretargeting for enhanced targeted radionuclide therapyMohamed Altai, Ábel Nagy, Pauline Granit, et al.
Pageof 1